Kurt J. Hilzinger - 30 Sep 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Kurt J. Hilzinger
Issuer symbol
HUM
Transactions as of
30 Sep 2024
Net transactions value
+$94,456
Form type
4
Filing time
02 Oct 2024, 19:22:19 UTC
Previous filing
02 Jul 2024
Next filing
03 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 19,448 30 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $94,456 +295 +2.2% $320.19 13,627 30 Sep 2024 Humana Common 295 Direct F3
holding HUM Restricted Stock Units 22,821 30 Sep 2024 Humana Common 22,821 Direct F1
holding HUM Restricted Stock Units 2,188 30 Sep 2024 Humana Common 2,188 Direct F2
holding HUM Restricted Stock Units 430 30 Sep 2024 Humana Common 430 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024.